Overview
Dirk Fahrenkamp practices practicing medicine in Hamburg, Germany.
His clinical expertise encompasses Myeloproliferative Neoplasms (MPN) and Myelofibrosis.
He is actively involved in clinical research, co-authoring 17 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Dirk Fahrenkamp
Is Dirk Fahrenkamp a top-rated expert for Myeloproliferative Neoplasms (MPN)?
MediFind is an objective health platform that identifies experts based on real-world data. Dirk Fahrenkamp is classified as an Experienced expert for Myeloproliferative Neoplasms (MPN), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Dirk Fahrenkamp participate in research or clinical trials?
Yes. Dirk Fahrenkamp has published 17 articles and abstracts on conditions like Myeloproliferative Neoplasms (MPN). You can view a list of Dirk Fahrenkamp's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- MyelofibrosisMr. Fahrenkamp isExperienced. Learn about Myelofibrosis.
- Myeloproliferative Neoplasms (MPN)Mr. Fahrenkamp isExperienced. Learn about Myeloproliferative Neoplasms (MPN).